Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Probiotics and live bacterial therapeutics are garnering increased attention for use in human health and have the potential to revolutionise the treatment of gastrointestinal diseases. However, a pervasive feature of bacteria that must be considered in the design of safe and effective probiotics and live bacterial therapeutics is their capacity for rapid evolution, both at the individual (epi)genetic level and in terms of population dynamics. Here we summarise gastrointestinal-specific evolution of bacteria, focussing on genetic and population levels of adaptation to factors such as carbon source availability, environmental stressors, and interactions with the native microbiome. We also address regulatory and safety considerations for the development of probiotics and live biotherapeutics from an evolutionary perspective, with a discussion of methods that utilise evolution to improve probiotic safety and efficacy via directed evolution, in comparison to another popular approach, genetic engineering.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145451PMC
http://dx.doi.org/10.1038/s41522-025-00734-6DOI Listing

Publication Analysis

Top Keywords

probiotics live
12
live bacterial
8
bacterial therapeutics
8
evolutionary adaptation
4
probiotics
4
adaptation probiotics
4
probiotics gut
4
gut selection
4
selection pressures
4
pressures optimization
4

Similar Publications

Bridging the Gut Microbiota and the Brain, Kidney, and Cardiovascular Health: The Role of Probiotics.

Probiotics Antimicrob Proteins

September 2025

Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília, SP, 17525-902, Brazil.

The symbiosis between intestinal bacteria and the human body's physiological processes can modulate health. The intestinal microbiota is linked to the development of neurotrophic factors; therefore, it is increasingly related to the modulation of nervous system pathologies. Moreover, microbiota can interfere with inflammation and oxidative stress, which are closely linked to cardiovascular risk factors and several other inflammatory conditions, such as kidney and neurodegenerative diseases.

View Article and Find Full Text PDF

Bifidobacterium breve B2798 and Its Heat-Killed Cells Alleviate Inflammation in Rats with DSS Model by Modulating Gut Microbiota.

Probiotics Antimicrob Proteins

September 2025

Inner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Key Laboratory of Dairy Products Processing, Ministry of Agriculture and Rural Affairs, Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, National Collection of Microbial Resource for Feed (Inner Mongol

While probiotics are widely recognized for their adjunctive benefits in ulcerative colitis treatment, the therapeutic potential of heat-killed cells remains underexplored. This study directly compared the efficacy of Bifidobacterium breve B2798 probiotics (LB group) and their heat-killed counterparts (DB group) in alleviating dextran sulfate sodium (DSS)-induced colitis in rats. Over a 21-day intervention, both treatments significantly mitigated colitis symptoms, including weight loss, colon damage, and splenomegaly, with heat-killed cells demonstrating superior histological improvement over live probiotics.

View Article and Find Full Text PDF

Human breast milk and its impact on inflammatory bowel disease.

J Smooth Muscle Res

September 2025

Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan.

Inflammatory bowel disease (IBD) is a term that describes disorders involving long-standing inflammation of tissues in the digestive tract. The onset and exacerbation of IBD is linked to multiple factors, including genetic and immunological influences, diet, and gut bacteria. Additionally, it is associated with a high risk of cancer.

View Article and Find Full Text PDF

Bacterial exopolysaccharides and live biotherapeutics: Orchestrating immune modulation and therapeutic potential in the gut microbiome era.

Biomed Pharmacother

September 2025

APC Microbiome Ireland, University College Cork, T12 YT20 Cork, Ireland; Cancer Research @UCC, College of Medicine and Health, University College Cork, T12 K8AF Cork, Ireland.

Microbial exopolysaccharides (EPS) are emerging as critical effector molecules orchestrating host immunity. Their remarkable structural diversity, driven by variations in monosaccharide composition, charge, and glycosidic linkages, dictates potent immunomodulatory functions through specific interactions with host pattern recognition receptors (CLRs, TLRs), triggering defined cellular responses and cytokine profiles, often with minimal toxicity. Beyond direct immune effects, EPS shape the gut environment by fortifying barrier integrity and acting as prebiotics.

View Article and Find Full Text PDF

(brine shrimp) is a vital live feed in aquaculture, providing essential nutrients during the early developmental stages of aquatic species. This study aimed to evaluate the efficacy of synbiotic-enriched as a live feed for hybrid catfish larvae ( × ), using locally isolated probiotics ( and ) and the commercial prebiotic inulin. The study was conducted in two phases.

View Article and Find Full Text PDF